Clinical trials for covid-19

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA);

clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development.

Learn more about the EU Clinical Trials Register including the source of the information and the legal basis.

The EU Clinical Trials Register currently displays 40115 clinical trials with a EudraCT protocol, of which 6570 are clinical trials conducted with subjects less than 18 years old.
The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (570)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

570 result(s) found for: covid-19. Displaying page 2 of 29.

EudraCT Number: 2020-001678-31	Sponsor Protocol Number: APHP200462	Start Date*: 2020-04-28
Sponsor Name:Assistance Publique Hopitaux de Paris
Full Title: Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Guérin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Work...
Medical condition: COVID 19 Health care workers (medical or non-medical) in French hospitals in direct contact with COVID-19 patients, including nurses, medical doctors and other personnel working in wards in charge...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-001527-14	Sponsor Protocol Number: 1	Start Date*: 2020-04-21
Sponsor Name:Erasmus MC
Full Title: COVID-19: addition of azithromycin to chloroquine treatment
Medical condition: COVID-19
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-001010-38

Sponsor Protocol Number: Ahus-NO-COVID-19

Start Date*: 2020-03-23

Sponsor Name:Akershus University Hospital

Full Title: NORWEGIAN CORONAVIRUS DISEASE 2019 (NO COVID-19) STUDY: AN OPEN LABELED RANDOMIZED CONTROLLED PRAGMATIC TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFEC...

Medical condition: SARS-COV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004855	10037373	Pulmonary disorder	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NO (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2021-000182-33	Sponsor Protocol Number: 76421	Start Date*: 2021-03-25
Sponsor Name:Radboudumc
Full Title: Effect of Bacillus Calmette-Guérin vaccination on the immunogenicity of the mRNA BNT162b2 COVID-19 vaccine in health care workers
Medical condition: Immunogenicity of the mRNA BNT162b2 COVID-19 vaccine.
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-000566-14

Sponsor Protocol Number: CoVigi

Start Date*: 2021-03-17

Sponsor Name:Masarykova univerzita

Full Title: Post-authorization Phase IV effectiveness and safety multicentric study of COVID-19 vaccines – CoVigi

Medical condition: COVID-19 Vaccines, monitoring of adverse events and evaluation of the immune response

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-002208-37

Sponsor Protocol Number: HVH237CIMM-COVID19

Start Date*: 2021-04-29

Sponsor Name:Respiratory Research Unit 237, Hvidovre Hospital

Full Title: The CIMMCov-study: A Single-center, Double-blinded, Randomized, 28-days, Parallel-group, study to evaluate the effect of Ciclesonide 320 mcg inhalation twice daily versus placebo on healthcare util...

Medical condition: COVID-19 pneumonia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004862	10084401	COVID-19 respiratory infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001421-31

Sponsor Protocol Number: QUINAVID-19

Start Date*: 2020-04-06

Sponsor Name:Sociedad Española de Farmacia Hospitalaria

Full Title: Clinical trial randomized, unblinded and controled for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.

Medical condition: SARS-CoV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10042613 - Surgical and medical procedures	10049924	Infection prophylaxis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001402-38

Sponsor Protocol Number: CTU/2020/352

Start Date*: 2020-10-20

Sponsor Name:University College London

Full Title: An international, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers.

Medical condition: Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2020-001546-19	Sponsor Protocol Number: ARGX-117-2001	Start Date*: 2020-04-21
Sponsor Name:argenx BV
Full Title: A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Efficacy of ARGX-117
Medical condition: PCR-confirmed Covid-19 infection
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2020-002039-31

Sponsor Protocol Number: covidstorm

Start Date*: 2020-06-17

Sponsor Name:Turku University Hospitla

Full Title: COVIDSTORM - study protocol COVID-19: Slavage TOcilizumab as a Rescue Measure

Medical condition: COVID-19 / new coronavirus disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	100000004862	10084382	Coronavirus disease 2019	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2020-001441-39

Sponsor Protocol Number: VIR20001

Start Date*: 2020-05-12

Sponsor Name:University of Oxford

Full Title: Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)

Medical condition: COVID-19, acute respiratory illness

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	100000004862	10053983	Corona virus infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-000890-10

Sponsor Protocol Number: MP0420-CP302

Start Date*: 2021-05-03

Sponsor Name:Molecular Partners AG

Full Title: A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19

Medical condition: Symptomatic COVID-19 in ambulatory patients

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004862	10084401	COVID-19 respiratory infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-000206-17	Sponsor Protocol Number: COVID19_7	Start Date*: 2021-03-10
Sponsor Name:Karolinska University Hospital
Full Title: Studies of ongoing and completed SARS-CoV-2 infection (which causes COVID-19) within the healthcare in Stockholm County, with regard to vaccinations.
Medical condition: Vaccination against COVID-19.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-000880-63	Sponsor Protocol Number: na	Start Date*: 2021-03-11
Sponsor Name:Skåne University Hospital, department of rheumatology in Lud and Malmö
Full Title: COVID-19 vaccine in patients with inflammatory rheumatic diseases: The impact of immunomodulating treatments on the antibody response, T cells response and protection against infection (COVID19-REUMA)
Medical condition: rheumatoid arthritis, SLE, systemic vasculitis, systemic sclerosis, spondylarthritis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-001654-21

Sponsor Protocol Number: KKS-279

Start Date*: 2020-09-16

Sponsor Name:Justus-Liebig-University Gießen

Full Title: Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumonia

Medical condition: COVID-19 pneumonia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	10021881 - Infections and infestations	10084380	COVID-19 pneumonia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-002503-19

Sponsor Protocol Number: 62586

Start Date*: 2020-07-08

Sponsor Name:UMC Utrecht

Full Title: BCG vaccination to Reduce the impact of COVID-19 in healthcare workers (BRACE) Trial

Medical condition: SARS-CoV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004848	10047490	Virus identification and serology	HLT

Population Age: Adults

Gender: Male, Female

Trial protocol: NL (Ongoing) GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2020-003643-29

Sponsor Protocol Number: VAC31518COV3009

Start Date*: 2020-11-10

Sponsor Name:Janssen Vaccines & Prevention B.V.

Full Title: A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older E...

Medical condition: Healthy Volunteers, with or without comorbidities (Prevention of SARS-CoV-2-mediated COVID-19)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Temporarily Halted) BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-002472-12

Sponsor Protocol Number: UMCN-AKF20.04

Start Date*: 2020-06-11

Sponsor Name:Radboud University Medical Center

Full Title: Lanadelumab for treatment of COVID-19 disease

Medical condition: COVID-19

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2020-005524-11	Sponsor Protocol Number: FNO-IMUNOR-2020	Start Date*: 2020-12-21
Sponsor Name:Fakultní nemocnice Ostrava
Full Title: Pilot, monocentre, phase-IV clnical trial assessing the clinical effect of per oral immunomodulation treatment using the IMUNOR® preparation in the prevention of COVID-19 disease
Medical condition: COVID-19 prevention
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)

EudraCT Number: 2020-004928-42

Sponsor Protocol Number: REM-ENY-01

Start Date*: 2020-10-12

Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium

Full Title: Open-label study to assess the safety of REMdesivir-HU as Eligible Novel therapY for moderate and severe Covid-19 patients

Medical condition: SARS-CoV-2 Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Ongoing)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

The status of studies in GB is no longer updated from 1.1.2021
For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI
EU Clinical Trials Register Service Desk: https://servicedesk.ema.europa.eu
European Medicines Agency © 1995-2021 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands Legal notice

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA